Sales & Marketing News | pharmaphorum

News

Lilly's Inluriyo is the second oral SERD to reach the US market for ESR1-mutated breast cancer, setting up a market tussle with Menarini's Orserdu.

News

After all the threats, it seems President Trump's tariffs on pharmaceuticals are coming to fruition, and a lot sooner than expected.

News

Biolinq gets an FDA green light for its autonomous, needle-free continuous glucose monitor, plus a roundup of other medtech developments.

News

Merck KGaA's CEO Belén Garijo will step down next year and will be replaced by the group's electronics boss Kai Beckmann.

News

MSD has moved a step closer to completing its acquisition of Verona Pharma, after a vote in favour of the transaction by the UK firm's shareholders.

News

AstraZeneca has elevated its challenge to Medicare drug price negotiation powers to the Supreme Court of the US.